Metformin add‐on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin add‐on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial
Authors
Keywords
-
Journal
World Psychiatry
Volume 19, Issue 1, Pages 69-80
Publisher
Wiley
Online
2020-01-11
DOI
10.1002/wps.20714
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials
- (2019) Davy Vancampfort et al. World Psychiatry
- Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
- (2017) Christoph U. Correll et al. World Psychiatry
- Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes: A systematic review and meta-analysis
- (2016) L.E. Chapman et al. DIABETES & METABOLISM
- A 52-Week Study of Olanzapine with a Randomized Behavioral Weight Counseling Intervention in Adolescents with Schizophrenia or Bipolar I Disorder
- (2016) Holland C. Detke et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders
- (2016) Christoph U. Correll et al. JOURNAL OF CLINICAL PSYCHIATRY
- Differential metformin dose-dependent effects on cognition in rats: role of Akt
- (2016) Dalia K. Mostafa et al. PSYCHOPHARMACOLOGY
- Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia
- (2016) John M. Kane et al. SCHIZOPHRENIA RESEARCH
- The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
- (2016) Helene Speyer et al. World Psychiatry
- Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
- (2016) Davy Vancampfort et al. World Psychiatry
- Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics
- (2016) Elaine H. Morrato et al. JAMA Psychiatry
- Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder
- (2016) Evdokia Anagnostou et al. JAMA Psychiatry
- Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics
- (2016) Britta Galling et al. JAMA Psychiatry
- Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics
- (2015) Angie Mae Rodday et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment
- (2015) Wei Zheng et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- Antipsychotic Use in Youth Without Psychosis
- (2015) Christoph U. Correll et al. JAMA Psychiatry
- Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naïve Patients
- (2014) Celso Arango et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics
- (2014) M. A. Raebel et al. PEDIATRICS
- Effects of metformin on weight loss
- (2014) Steven K. Malin et al. Current Opinion in Endocrinology Diabetes and Obesity
- Metformin for Antipsychotic-Related Weight Gain and Metabolic Abnormalities: When, for Whom, and for How Long?
- (2013) Christoph U. Correll et al. AMERICAN JOURNAL OF PSYCHIATRY
- Should we rely on the Kenward-Roger approximation when using linear mixed models if the groups have different distributions?
- (2013) Jaume Arnau et al. BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY
- National Trends in the Mental Health Care of Children, Adolescents, and Adults by Office-Based Physicians
- (2013) Mark Olfson et al. JAMA Psychiatry
- Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods
- (2013) Gloria M Reeves et al. Child and Adolescent Psychiatry and Mental Health
- Metabolic Screening in Children Receiving Antipsychotic Drug Treatment
- (2012) Elaine H. Morrato et al. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)
- (2011) T. Scott Stroup et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lack of Effect of Stimulant Combination with Second-Generation Antipsychotics on Weight Gain, Metabolic Changes, Prolactin Levels, and Sedation in Youth with Clinically Relevant Aggression or Oppositionality
- (2009) Julie B. Penzner et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
- (2009) CHRISTOPH U. CORRELL et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
- (2008) Linmarie Sikich et al. AMERICAN JOURNAL OF PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now